NO992399D0 - Stabiliserte farmas°ytiske preparater basert pÕ quinupristin og dalfopristin samt deres fremstilling - Google Patents

Stabiliserte farmas°ytiske preparater basert pÕ quinupristin og dalfopristin samt deres fremstilling

Info

Publication number
NO992399D0
NO992399D0 NO992399A NO992399A NO992399D0 NO 992399 D0 NO992399 D0 NO 992399D0 NO 992399 A NO992399 A NO 992399A NO 992399 A NO992399 A NO 992399A NO 992399 D0 NO992399 D0 NO 992399D0
Authority
NO
Norway
Prior art keywords
dalfopristin
quinupristin
preparation
well
pharmaceutical preparations
Prior art date
Application number
NO992399A
Other languages
English (en)
Other versions
NO992399L (no
Inventor
Jean-Paul Bounine
Guillaume Conrath
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO992399L publication Critical patent/NO992399L/no
Publication of NO992399D0 publication Critical patent/NO992399D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO992399A 1996-11-19 1999-05-19 Stabiliserte farmas°ytiske preparater basert pÕ quinupristin og dalfopristin samt deres fremstilling NO992399D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614062A FR2755857B1 (fr) 1996-11-19 1996-11-19 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
PCT/FR1997/002047 WO1998022107A1 (fr) 1996-11-19 1997-11-14 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation

Publications (2)

Publication Number Publication Date
NO992399L NO992399L (no) 1999-05-19
NO992399D0 true NO992399D0 (no) 1999-05-19

Family

ID=9497744

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992399A NO992399D0 (no) 1996-11-19 1999-05-19 Stabiliserte farmas°ytiske preparater basert pÕ quinupristin og dalfopristin samt deres fremstilling

Country Status (45)

Country Link
US (1) US5994338A (no)
EP (1) EP0949923B1 (no)
JP (1) JP4278115B2 (no)
KR (1) KR100530836B1 (no)
CN (1) CN1146417C (no)
AP (1) AP998A (no)
AR (1) AR008695A1 (no)
AT (1) ATE223217T1 (no)
AU (1) AU740291B2 (no)
BG (1) BG63621B1 (no)
BR (1) BR9713087A (no)
CA (1) CA2271095C (no)
CO (1) CO4910113A1 (no)
CZ (1) CZ299913B6 (no)
DE (1) DE69715247T2 (no)
DK (1) DK0949923T3 (no)
DZ (1) DZ2349A1 (no)
EA (1) EA002025B1 (no)
EE (1) EE03668B1 (no)
ES (1) ES2179375T3 (no)
FR (1) FR2755857B1 (no)
HK (1) HK1022832A1 (no)
HR (1) HRP970615B1 (no)
HU (1) HUP9904327A3 (no)
IL (2) IL129607A0 (no)
IN (1) IN187038B (no)
JO (1) JO1992B1 (no)
MA (1) MA26448A1 (no)
MY (1) MY123805A (no)
NO (1) NO992399D0 (no)
NZ (1) NZ334949A (no)
OA (1) OA11047A (no)
PE (1) PE13999A1 (no)
PL (1) PL190164B1 (no)
PT (1) PT949923E (no)
RS (1) RS49608B (no)
SA (1) SA97180645B1 (no)
SK (1) SK284311B6 (no)
TN (1) TNSN97184A1 (no)
TR (1) TR199901096T2 (no)
TW (1) TW474816B (no)
UA (1) UA59376C2 (no)
UY (1) UY24780A1 (no)
WO (1) WO1998022107A1 (no)
ZA (1) ZA9710435B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772272B1 (fr) * 1997-12-16 2000-01-14 Rhone Poulenc Rorer Sa Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
EP1674107B8 (en) * 1998-09-25 2017-01-25 Cubist Pharmaceuticals LLC Use of daptomycin
KR100613136B1 (ko) * 1999-03-03 2006-08-17 일라이 릴리 앤드 캄파니 미셀-형성 계면활성제를 함유하는 에키노칸딘 제약학적조제물
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6119269A (en) * 1999-09-23 2000-09-19 Imler; Jack Fishing vest with removable storage container system
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
FR2812549B1 (fr) * 2000-08-03 2003-03-21 Aventis Pharma Sa Associations dalfopristine/quinupristine avec le cefpirome
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2599036B1 (fr) * 1986-05-22 1988-09-09 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CO4910113A1 (es) 2000-04-24
FR2755857A1 (fr) 1998-05-22
JP4278115B2 (ja) 2009-06-10
MA26448A1 (fr) 2004-12-20
IL129607A0 (en) 2000-02-29
TNSN97184A1 (fr) 2005-03-15
HUP9904327A3 (en) 2002-03-28
UY24780A1 (es) 2001-08-27
SK284311B6 (sk) 2005-01-03
WO1998022107A1 (fr) 1998-05-28
EP0949923B1 (fr) 2002-09-04
BG103412A (en) 2000-06-30
AU5125698A (en) 1998-06-10
NO992399L (no) 1999-05-19
OA11047A (fr) 2003-03-07
SK66099A3 (en) 2000-01-18
FR2755857B1 (fr) 1998-12-24
PT949923E (pt) 2003-01-31
SA97180645B1 (ar) 2005-12-12
UA59376C2 (uk) 2003-09-15
CZ299913B6 (cs) 2008-12-29
CN1233959A (zh) 1999-11-03
HK1022832A1 (en) 2000-08-25
EA002025B1 (ru) 2001-12-24
RS49608B (sr) 2007-06-04
PL190164B1 (pl) 2005-11-30
DK0949923T3 (da) 2002-12-23
ATE223217T1 (de) 2002-09-15
DE69715247D1 (de) 2002-10-10
TR199901096T2 (xx) 1999-07-21
ZA9710435B (en) 1998-06-10
ES2179375T3 (es) 2003-01-16
AR008695A1 (es) 2000-02-09
EE9900127A (et) 1999-12-15
BG63621B1 (bg) 2002-07-31
HRP970615A2 (en) 1998-08-31
CZ174899A3 (cs) 1999-08-11
JP2001504475A (ja) 2001-04-03
YU22499A (sh) 2002-03-18
AP998A (en) 2001-08-09
PE13999A1 (es) 1999-05-05
US5994338A (en) 1999-11-30
EA199900479A1 (ru) 2000-02-28
DE69715247T2 (de) 2003-04-30
CN1146417C (zh) 2004-04-21
IN187038B (no) 2001-12-29
IL129607A (en) 2006-08-20
CA2271095A1 (fr) 1998-05-28
KR100530836B1 (ko) 2005-11-23
DZ2349A1 (fr) 2002-12-28
BR9713087A (pt) 2000-03-28
CA2271095C (fr) 2004-08-03
KR20000053343A (ko) 2000-08-25
AU740291B2 (en) 2001-11-01
TW474816B (en) 2002-02-01
EE03668B1 (et) 2002-04-15
EP0949923A1 (fr) 1999-10-20
JO1992B1 (en) 1999-05-15
HUP9904327A2 (hu) 2000-06-28
NZ334949A (en) 2000-12-22
HRP970615B1 (en) 2002-12-31
MY123805A (en) 2006-06-30

Similar Documents

Publication Publication Date Title
NO921012D0 (no) Farmasoeytiske preparater og deres anvendelse
NO922506L (no) Farmasoeytiske preparat
NO2009028I1 (no) Kinazolin-derivater, anvendelse og fremstilling derav, samt farmasøytisk preparat
NO974618D0 (no) Farmasöytiske preparater for intranasal administrasjon
NO965103L (no) Bicykliske aromatiske forbindelser, anvendelse derav, og farmasöytiske og kosmetiske preparater
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
DE60038268D1 (de) Kosmetische Zubereitungen
NO306401B1 (no) Oksazolidindionderivater, farmasöytisk preparat inneholdende slike derivater, og deres anvendelse
DK1035865T3 (da) HIV-1-Tat eller derivater deraf til profylaktisk og terapeutisk vaccination
DE59710701D1 (de) Kosmetische zubereitungen
NO985368D0 (no) Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene
DE59804418D1 (de) Kosmetische zubereitungen
DE59704397D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
NO307510B1 (no) Bicykliske aromatiske forbindelser, deres anvendelse og farmasøytiske og kosmetiske preparater derav
DE59709718D1 (de) Kosmetische zubereitungen
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
DK162491D0 (da) Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
NO20001905D0 (no) Forbindelser og deres anvendelse i farmasøytiske eller kosmetiske preparater
NO992399L (no) Stabiliserte farmas°ytiske preparater basert pÕ quinupristin og dalfopristin samt deres fremstilling
NO983472D0 (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
DK1037652T3 (da) Farmaceutiske præparater baseret på dalfopristin og quinupristin samt deres fremstilling
ATE298576T1 (de) Arzneizubereitungen
DE50006823D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application